Vanguard Investments Australia
PBH icon

Vanguard Investments Australia’s Prestige Consumer Healthcare PBH Stock Holding History

Vanguard Investments Australia’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Hold
12,184
– – ﹤0.01% 1592
2026
Q1 		$722K Buy
+12,184
New +$790K ﹤0.01% 1392

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Investments Australia's PBH Position: Q2 2026 in Review

Vanguard Investments Australia held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 12,184 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Vanguard Investments Australia first reported a position in PBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $722K in Q1 2026. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Vanguard Investments Australia held 12,184 shares of Prestige Consumer Healthcare worth $576K as of Q2 2026.
  • Vanguard Investments Australia left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
  • Prestige Consumer Healthcare made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1592 holding.
  • Vanguard Investments Australia first reported a position in Prestige Consumer Healthcare in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Prestige Consumer Healthcare position peaked at $722K in Q1 2026.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.